Related Experiment Video
Updated: Apr 19, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Systemic sclerosis in 2014: Advances in cohort enrichment shape future of trial design
Yannick Allanore1, Oliver Distler2
1Department of Rheumatology A, Medicine Faculty, Paris Descartes University, 27 Rue du Faubourg Saint Jacques, Cochin Hospital, 75014 Paris, France.
Abstract:
The treatment and study of systemic sclerosis (SSc) is entering a new era with the reporting and preparation of several randomized controlled trials according to an improved understanding of SSc pathogenesis. Advances in trial designs reported in 2014 should now be built upon with further improvements to patient selection to enable targeting of therapies to specific subgroups of patients with SSc.
Insights
Systemic sclerosis (SSc) treatment is advancing with new clinical trials. Future research should refine patient selection for targeted therapies, improving SSc management.
Area of Science:
- Rheumatology
- Immunology
- Clinical Trials
Background:
- Systemic sclerosis (SSc) pathogenesis understanding has improved.
- Several randomized controlled trials (RCTs) in SSc are emerging.
- Previous trial designs from 2014 require further development.
Purpose of the Study:
- To highlight the evolving landscape of systemic sclerosis treatment.
- To emphasize the need for enhanced patient stratification in SSc clinical trials.
- To advocate for precision medicine approaches in SSc therapy.
Main Methods:
- Review of recent advancements in SSc clinical trial design.
- Analysis of the impact of improved SSc pathogenesis knowledge.
- Discussion on strategies for optimizing patient selection in SSc studies.
Main Results:
- The field of SSc treatment is undergoing significant transformation.
- Current trial designs are based on a better grasp of SSc.
- There is a clear need for improved patient subgroup identification.
Conclusions:
- Systemic sclerosis research is entering a new era of therapeutic development.
- Building upon 2014 trial design advancements is crucial.
- Enhanced patient selection will enable targeted SSc therapies for specific subgroups.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Related Concept Videos
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Multiple Sclerosis l: Introduction
Cancer Survival Analysis
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...